Trial Profile
A Study to Examine Immunological Response in HIV-Infected Patients Receiving the Seasonal Influenza Vaccine.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 May 2023
Price :
$35
*
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Pharmacodynamics
- 09 Feb 2016 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
- 17 May 2015 Planned End Date changed from 1 Sep 2014 to 1 Sep 2016, as per ClinicalTrials.gov.
- 17 May 2015 Planned primary completion date changed from 1 Jun 2014 to 1 Jun 2016, as per ClinicalTrials.gov.